Eupraxia Pharmaceuticals (EPRX) Liabilities and Shareholders Equity (2022 - 2026)
Eupraxia Pharmaceuticals' Liabilities and Shareholders Equity was $139.91 million in the quarter ended Jun 30, 2026, up 492.9% from $23.6 million a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Liabilities and Shareholders Equity at Eupraxia Pharmaceuticals came in at $86.15 million, up 146.5% from the prior year.
- Liabilities and Shareholders Equity has now increased for three consecutive years, with a three-year compound annual growth rate of 65.2% (years ended Dec 2022 to Dec 2025).
- In earlier years, Liabilities and Shareholders Equity was $34.94 million in the year ended Dec 31, 2024 (+72.4%), $20.27 million in the year ended Dec 31, 2023 (+6.0%) and $19.12 million in the year ended Dec 31, 2022.
- Quarterly Liabilities and Shareholders Equity has moved between $10.36 million (the quarter ended Sep 30, 2024) and $145.35 million (the quarter ended Mar 31, 2026) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity has increased for four straight quarters, with growth averaging 267.8% over the last seven quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was the quarter ended Sep 30, 2025 (growth of 791.0%); the worst was the quarter ended Mar 31, 2025 (a decline of 20.2%).
- Per Business Quant data, EPRX's Liabilities and Shareholders Equity in the three quarters before the quarter ended Jun 30, 2026 was $145.35 million (quarter ended Mar 31, 2026), $86.15 million (quarter ended Dec 31, 2025) and $92.35 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | 139.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.91 Mn |
| Mar 31, 2026 | 145.35 Mn |
| Dec 31, 2025 | 86.15 Mn |
| Sep 30, 2025 | 92.35 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 29.23 Mn |
| Dec 31, 2024 | 34.94 Mn |
| Sep 30, 2024 | 10.36 Mn |
| Jun 30, 2024 | 24.98 Mn |
| Mar 31, 2024 | 36.64 Mn |
| Dec 31, 2023 | 20.27 Mn |
| Dec 31, 2022 | 19.12 Mn |
API Access
Eupraxia Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();